Articles
Regeneus secures rights to cancer vaccine for humans
Regeneus (ASX:RGS) has picked up exclusive rights to an autologous therapeutic cancer vaccine for humans, after having already secured the exclusive licence for veterinary applications. [ + ]
Sirtex achieves 10 years of quarterly sales growth
Sirtex (ASX:SRT) hit a milestone during the June quarter, recording its 40th consecutive quarter of sequential growth in dose sales of its SIR-Spheres liver cancer treatment. [ + ]
The physical effects of magic mushrooms
Researchers have examined the brain effects of the psychedelic chemical in magic mushrooms, called 'psilocybin', revealing the physical changes the chemical makes to the brain. [ + ]
Quantifying protein-protein interactions with dynamic light scattering
A researcher from the University of Copenhagen has published a study outlining the benefits of quantifying protein-protein interactions (PPI) using automated dynamic light scattering (DLS) in high-throughput screening (HTS) mode to identify promising candidates for drug-like properties and establish the suitability of formulations before entering extended stability studies. [ + ]
Simavita doubles Aust sales, books first US revenues
Simavita (ASX:SVA) revealed it had doubled Australian monthly revenues for its incontinence management products and its distribution partner has commenced sales in the US. [ + ]
The fall of emperor penguins
Reductions in Antarctic sea ice suggest that emperor penguin colonies will shrink by the end of the century. [ + ]
Admedus expects $9m in income for FY13-14
Admedus (ASX:AHZ) made good progress with the commercialisation of CardioCel during the financial year and hopes to report the results of its subsidiary's HSV-2 trial next quarter. [ + ]
Anatara seeking partners as LSQ finds one
Anatara Lifesciences used BIO 2014 to seek partners for a non-antibiotic diarrhoea treatment, while Life Sciences Queensland has signed an MoU with biotech accelerator Bioindustrial Innovation Canada. [ + ]
Entrepreneurs' Infrastructure Programme seeks comment
AusBiotech has made preliminary comment regarding the establishment of the Entrepreneurs' Infrastructure Programme (EIP), based on questions posed in the EIP Discussion Paper (June 2014). [ + ]
Mesoblast MPCs improve outcomes in heart failure
Mesoblast's (ASX:MSB) mesenchymal precursor cells were associated with improved outcomes in end-stage heart failure patients needing to be weaned off LVADs during a recent trial. [ + ]
UBI gets first test-strip order from Siemens
Universal Biosensors (ASX:UBI) announced a milestone in its tie-up with Siemens Healthcare Diagnostics to develop point-of-care coagulation tests - the first commercial order for PT-INR strips. [ + ]
Bionomics licenses BNC375 for up to $558m
Bionomics (ASX:BNO) has signed a research collaboration and licensing deal with Merck covering BNC375, a treatment candidate for Alzheimer's and other CNS conditions. [ + ]
First images of a microorganism's drug manufacturing line
Researchers at the University of Michigan (UM) have obtained the first three-dimensional snapshots of the 'assembly line' within microorganisms that naturally produces antibiotics and other drugs. [ + ]
A spectroscopic technique for understanding photochemical reactions
Using photochemical reactions to our advantage requires a deep understanding of the interplay between the electrons and atomic nuclei within a molecular system after that system has been excited by light. [ + ]
How application and workflow affect pipette selection
By choosing the right pipetting system and eliminating risk and variability from pipetting procedures, users can achieve enhanced accuracy, reduced costs and better overall productivity. [ + ]
